Screener
Vir Biotechnology, Inc. VIR Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s total assets?
- Vir Biotechnology, Inc. (VIR) reported total assets of $1.21B in Q2 2026.
- How has Vir Biotechnology, Inc.'s total assets changed year-over-year?
- Vir Biotechnology, Inc.'s total assets increased by 1.9% year-over-year, from $1.19B to $1.21B.
- What is the long-term trend for Vir Biotechnology, Inc.'s total assets?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s total assets has grown at a 1.8% compound annual growth rate (CAGR), from $918.76M to $1B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Vir Biotechnology, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude